Introduction: Endovenous ablation may not always be necessary for every patient with chronic venous insufficiency who has an indication for endovenous ablation. This study investigates whether compression stockings and Daflon® can be as effective for some patients with CEAP two in chronic venous insufficiency. Methods: In this study, 137 patients who had endovenous ablation indication received plethysmographical hemodynamic tests and were divided into two groups. Group 1 had normal venous hemodynamics and received compression stockings and Daflon®. Group 2 had abnormal function and received laser ablation. All patients were reevaluated after 6 months. Results: The study showed that there was no statistically significant difference between Groups 1 and 2 in the 6th month measurements after the treatments. Conclusion: As a result, we do not find it appropriate and do not recommend that every patient with complaints of chronic venous insufficiency and an indication for endovenous ablation undergo ablation without evaluating lower extremity venous hemodynamics.
LeeB-BNicolaidesANMyersK, et al.Venous hemodynamic changes in lower limb venous disease: the UIP consensus according to scientific evidence. Int Angiol2016; 35(3): 236–352.
2.
LabropoulosN. How does chronic venous disease progress from the first symptoms to the advanced stages? A review. Adv Ther2019; 36(1): 13–19.
3.
LeeAJRobertsonLABoghossianSM, et al.Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg2015; 3(1): 18–26.
4.
GloviczkiPComerotaAJDalsingMC, et al.The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg2011; 53(5): 2S–48S.
5.
ChristopoulosDNicolaidesASzendroG. Venous reflux: quantification and correlation with the clinical severity of chronic venous disease. J Brit Surg1988; 75(4): 352–356.
6.
CriadoEFarberMAMarstonWA, et al.The role of air plethysmography in the diagnosis of chronic venous insufficiency. J Vasc Surg1998; 27(4): 660–670.
7.
YounYJLeeJ. Chronic venous insufficiency and varicose veins of the lower extremities. Kor J Intern Med2019; 34(2): 269.
8.
BushRComerotaAMeissnerM, et al.Recommendations for the medical management of chronic venous disease: the role of micronized purified flavanoid fraction (MPFF) recommendations from the Working Group in Chronic Venous Disease (CVD) 2016. Phlebology2017; 32(1_suppl): 3–19.
9.
JantetG. Chronic venous insufficiency: worldwide results of the RELIEF study. Angiology2002; 53(3): 245–256.
10.
UlloaJH. Micronized purified flavonoid fraction (MPFF) for patients suffering from chronic venous disease: a review of new evidence. Adv Ther2019; 36: 20–25.
11.
EggenCAAlozaiTPronkP, et al.Ten-year follow-up of a randomized controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia. J Vasc Surg2022; 10(3): 646–653. e1.
12.
HamannSAGiangJDe MaeseneerMG, et al.Editor's choice–five year results of great saphenous vein treatment: a meta-analysis. Eur J Vasc Endovasc Surg2017; 54(6): 760–770.
13.
HogganBCameronAMaddernG. Systematic review of endovenous laser therapy versus surgery for the treatment of saphenous varicose veins. Ann Vasc Surg2009; 23(2): 277–287.
14.
KheirelseidEACroweGSehgalR, et al.Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins. J Vasc Surg2018; 6(2): 256–270.
15.
BozkurtAKYılmazMF. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology2016; 31(1_suppl): 106–113.
16.
GloviczkiPGloviczkiM. Guidelines for the management of varicose veins. Phlebology2012; 27(1_suppl): 2–9.
17.
LytleBWLoopFDCosgroveDM, et al.Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg1985; 89(2): 248–258.
18.
HiraiMNaikiKNakayamaR. Chronic venous insufficiency in primary varicose veins evaluated by plethysmographic technique. Angiology1991; 42(6): 468–472.
19.
AherneTMRyanÉJBolandMR, et al.Concomitant vs. staged treatment of varicose tributaries as an adjunct to endovenous ablation: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg2020; 60(3): 430–442.
20.
ErbenYVasquezILiY, et al.A multi-institutional review of endovenous thermal ablation of the saphenous vein finds male sex and use of anticoagulation are predictors of long-term failure. Phlebology2021; 36(4): 283–289.
21.
PaveiPSpreaficoGBernardiE, et al.Favorable long-term results of endovenous laser ablation of great and small saphenous vein incompetence with a 1470-nm laser and radial fiber. J Vasc Surg: Venous and Lymphatic Disorders2021; 9(2): 352–360.
22.
CutlerBKiguchiMMKochubeyM, et al.Opportunity cost comparison of radiofrequency ablation and cyanoacrylate adhesive venous closures. J Vasc Surg2023; 11(1): 39–45. e1.
23.
LurieFPassmanMMeisnerM, et al.The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg2020; 8(3): 342–352.
24.
OrtegaMAFraile-MartínezOGarcía-MonteroC, et al.Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med2021; 10(15): 3239.
25.
NicolaidesAKakkosSBaekgaardN, et al.Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol2018; 37(3): 181–254.
26.
NicolaidesAN. The benefits of micronized purified flavonoid fraction (MPFF) throughout the progression of chronic venous disease. Berlin, Germany: Springer, 2020, pp. 1–5.
27.
KorthuisRJlU. Experimental models to investigate inflammatory processes in chronic venous insufficiency. Microcirculation2000; 7(S1): S13–S22.
28.
MaggioliA. Chronic venous disorders: pharmacological and clinical aspects of micronized purified flavonoid fraction. Phlebolymphology2016; 23(2): 82–91.
29.
MakedonovIKahnSRGalanaudJ-P. Prevention and management of the post-thrombotic syndrome. J Clin Med2020; 9(4): 923.
